RV01
|
R649802-5mg
|
≥98% |
1016897-10-1 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
RV01
|
R649802-50mg
|
≥98% |
1016897-10-1 |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
RV01
|
R649802-25mg
|
≥98% |
1016897-10-1 |
25mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
RV01
|
R649802-10mg
|
≥98% |
1016897-10-1 |
10mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
RV01
|
R649802-100mg
|
≥98% |
1016897-10-1 |
100mg
|
¥ 22500.9
|
期货,请咨询 |
阿拉丁 |
(S)-Rivastigmine-d6tartrate
|
R649758-5mg
|
≥99% |
194930-00-2 |
5mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
(S)-Rivastigmine-d6tartrate
|
R649758-1mg
|
≥99% |
194930-00-2 |
1mg
|
¥ 3600.9
|
期货,请咨询 |
阿拉丁 |
Retagliptin
|
R649721-5mg
|
≥98% |
1174122-54-3 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
Retagliptin
|
R649721-50mg
|
≥98% |
1174122-54-3 |
50mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
Retagliptin
|
R649721-10mg
|
≥98% |
1174122-54-3 |
10mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Retagliptin
|
R649721-100mg
|
≥98% |
1174122-54-3 |
100mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
Resorcinolnaphthalein
|
R649699-50mg
|
≥99% |
41307-63-5 |
50mg
|
¥ 1450.9
|
期货,请咨询 |
阿拉丁 |
Resorcinolnaphthalein
|
R649699-25mg
|
≥99% |
41307-63-5 |
25mg
|
¥ 960.9
|
期货,请咨询 |
阿拉丁 |
Resorcinolnaphthalein
|
R649699-10mg
|
≥99% |
41307-63-5 |
10mg
|
¥ 600.9
|
期货,请咨询 |
阿拉丁 |
Resorcinolnaphthalein
|
R649699-100mg
|
≥99% |
41307-63-5 |
100mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Rosmanol
|
R649683-5mg
|
≥98% |
80225-53-2 |
5mg
|
¥ 1950.9
|
期货,请咨询 |
阿拉丁 |
Rosmanol
|
R649683-25mg
|
≥98% |
80225-53-2 |
25mg
|
¥ 6300.9
|
期货,请咨询 |
阿拉丁 |
Rosmanol
|
R649683-1mg
|
≥98% |
80225-53-2 |
1mg
|
¥ 685.9
|
期货,请咨询 |
阿拉丁 |
Rosmanol
|
R649683-10mg
|
≥98% |
80225-53-2 |
10mg
|
¥ 3100.9
|
期货,请咨询 |
阿拉丁 |
RSV-IN-7
|
R649626-5mg
|
≥98% |
2070852-76-3 |
5mg
|
¥ 8200.9
|
期货,请咨询 |
阿拉丁 |
RSV-IN-7
|
R649626-1mg
|
≥98% |
2070852-76-3 |
1mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
RSV-IN-7
|
R649626-10mg
|
≥98% |
2070852-76-3 |
10mg
|
¥ 13200.9
|
期货,请咨询 |
阿拉丁 |
RORγt agonist 3
|
R649608-5mg
|
≥98% |
2664106-24-3 |
5mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
RORγt agonist 3
|
R649608-1mg
|
≥98% |
2664106-24-3 |
1mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |